Odyssey Health (ODYY) Net Income Growth (1y) (2015 - 2026)
Odyssey Health (ODYY) Net Income Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 13.84% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -27.18% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 14.80% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 75.09% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 12.92% |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - | -333.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -333.24% |
| Jan 31, 2026 | -170.14% |
| Oct 31, 2025 | 38.52% |
| Jul 31, 2025 | -239.66% |
| Apr 30, 2025 | 59.87% |
| Jan 31, 2025 | 83.06% |
| Oct 31, 2024 | -20.46% |
| Jul 31, 2024 | 118.87% |
| Apr 30, 2024 | 63.04% |
| Jan 31, 2024 | 22.71% |
| Oct 31, 2023 | 74.96% |
| Jul 31, 2023 | 30.78% |
| Apr 30, 2023 | 58.57% |
| Jan 31, 2023 | 23.07% |
| Oct 31, 2022 | -30.54% |
| Jul 31, 2022 | 54.37% |
| Apr 30, 2022 | 75.11% |
| Jan 31, 2022 | -151.32% |
| Oct 31, 2021 | -131.38% |
| Jul 31, 2021 | -60.39% |